Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- DIAGNOSTIC NEWS IN BRIEF
March 5, 2001
- Korosho to Deal with Biologics in Earnest
March 5, 2001
- Korosho to Issue GL Regarding NAT for HBV, HCV, HIV
March 5, 2001
- JPMA Invites Participation in Protein Structure Analysis Consortium
March 5, 2001
- 39 New Drugs Approved in 2000: PMSB
March 5, 2001
- Individual Health Insurance Cards to Be Introduced in April
March 5, 2001
- JPMA Calls For Maintenance of NHI Price Listing by Brand Name
March 5, 2001
- GL for Investigational Use of ES Cells Proposed
March 5, 2001
- Kemporen Proposes Series of Measures to Contain Medical Spending
March 5, 2001
- Fujisawa Ties Up with Fuji RC for Respiratory Care Devices
March 5, 2001
- Dissolution Test Methods Proposed for 13 Active Ingredients
March 5, 2001
- MIC Receives Applications for Clinical Trials via Toll-free Dial
March 5, 2001
- Nomura Securities Starts Nomura Bio Network
March 5, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
March 5, 2001
- Novartis: Group Sales Up 10% to CHF 35.8 Bil.
March 5, 2001
- 60% of Manufacturer-hired MRs Are Interested in Contract MRs
March 5, 2001
- Korosho to Present Drug Pricing Reform Policy by Summer
March 5, 2001
- Raloxifene Reduces Risk of Breast Cancer
March 5, 2001
- BULLETIN
March 5, 2001
- Government Takes Measures against Stevens-Johnson Syndrome
March 5, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…